d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] First study of intravenous catumaxumab (Removab) in patients with EpCam expressing epithelial solid tumors [Country] DK [Cancer type] 
Solide tumores
Nordic NECT - Inclusion completed
Cancer type